Aytu BioPharma (0A8M.LSE) Q4 2024 Earnings

13NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.82
-0.61
-0.41
-0.2

Details

Expected EPS
-0.34
Actual EPS
-0.2
Surprise EPS
0.14
Surprise Percent
+41.18%

Description

Aytu BioPharma (0A8M.LSE) has reported earnings of -0.2 per share for Q4 2024.

0 Comments

Share your thoughts